Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: Increasing impact or future epidemic?

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 9, 2010, Pages 1083-1088

  Marcos Gragera, R ^a,b   Vilar Coromina, N ^c,d   Galceran, J ^e   Borras J ^e,f   Cleries R ^g,h   Ribes, J ^g,h   Gispert, R ⁱ   Izquierdo, A ^a   Borràs, Jm ^g,h  

^a GENERALITAT DE CATALUNYA   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

^c Hospital Sant Jaume de Calella   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^f UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^g Department of Health ^*  (Spain)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ HOSPITAL CLÍNIC   (Spain)

Author keywords

Bayesian age period cohort model; cutaneous malignant melanoma; incidence; mortality; projections

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CUTANEOUS MALIGNANT MELANOMA; EPIDEMIC; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY; PRIORITY JOURNAL; SPAIN; TREND STUDY;

FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; SKIN NEOPLASMS; SPAIN;

EID: 77955255548     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03602.x     Document Type: Article

References (37)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. IARCPress, Lyon, 2004.
2. Curado MP, Edwards B, Shin HR et al. Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publications No. 160, IARC, Lyon, 2007.
3. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002 146 (Suppl. 61 1 6.
4. Clark LN, Shin DB, Troxel AB, Khan S, Sober AJ, Ming ME. Association between the anatomic distribution of melanoma and sex. J Am Acad Dermatol 2007 56 : 768 773.
5. Ocaña-Riola R, Martínez-García C, Serrano S, Buendia-Eisman A, Ruiz-Baena C, Canela-Soler J. Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992. Eur J Epidemiol 2001 17 : 169 174.
6. Veierod MB, Weiderpass E, Thorn M et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 2003 95 : 1530 1538.
7. International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 2007 120 : 1116 1122.
8. Whiteman DC. Melanoma and sun exposure. Lancet 1995 346 : 1224 1225.
9. Whiteman DC, Green AC. Melanoma and sun exposure: where are we now? Int J Dermatol 1999 38 : 481 489.
10. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001 12 : 69 82.
11. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004 150 : 179 185.
12. Breslow NE, Day NE. Statistical methods in cancer research. Volume II - the design and analysis of cohort studies. IARC Sci Publ 1987 82 : 1 406.
13. Bray I. Application of Markov chain Monte Carlo methods to projecting cancer incidence and mortality. Appl Statist 2002 51 : 151 164.
14. Bashir SA, Esteve J. Projecting cancer incidence and mortality using Bayesian age-period-cohort models. J Epidemiol Biostat 2001 6 : 287 296.
15. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde AJ. Bayesian measures of model complexity and fit (with discussion). J Roy Stat Soc B 2002 64 : 583 639.
16. Sturtz S, Ligges U, Gelman A. A package for running WinBUGS from R. J Stat Soft 2005 12 : 1 16.
17. Cléries R, Ribes J, Esteban L, Martínez JM, Borras JM. Time trends of breast cancer mortality in Spain during the period 1977-2001 and Bayesian approach for projections during 2002-2016. Ann Oncol 2006 17 : 1783 1791.
18. Espey DK, Wu XC, Swan J et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007 110 : 2119 2152.
19. Downing A, Yu XQ, Newton-Bishop J, Forman D. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003. Int J Cancer 2008 123 : 861 866.
20. Lipsker DM, Hedelin G, Heid E, Grosshans EM, Cribier BJ. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol 1999 135 : 1451 1456.
21. Murray CS, Stockton DL, Doherty VR. Thick melanoma: the challenge persists. Br J Dermatol 2005 152 : 104 109.
22. Boyle P, Autier P, Bartelink H et al. European code against cancer and scientific justification: third version (2003). Ann Oncol 2003 14 : 973 1005.
23. Boyle P, Dore JF, Autier P, Ringborg U. Cancer of the skin: a forgotten problem in Europe. Ann Oncol 2004 15 : 5 6.
24. Spanish Cancer Strategy of the NHS. Ministry of Health and Social Policy, Madrid, 2009. (accessible at http://www.msps.es).
25. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off?. Melanoma Res 2004 14 : 301 309.
26. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000 82 : 1887 1891.
27. Scotto J, Pitcher H, Lee JA. Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. Int J Cancer 1991 49 : 490 497.
28. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994 BMJ 1996 312 : 1121 1125.
29. Bulliard JL, Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. Int J Epidemiol 2000 29 : 416 423.
30. Cayuela A, Rodriguez-Dominguez S, Lapetra-Peralta J, Conejo-Mir JS. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001 Br J Dermatol 2005 152 : 997 1000.
31. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003 107 : 119 126.
32. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 2006 17 : 21 27.
33. de Vries E, Nijsten TE, Visser O et al. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol 2008 19 : 583 589.
34. Galceran J, Puidefabregas A, Ribas G, Izquierdo A, Pareja L, Marcos-Gragera R. Evolución de la supervivencia del cáncer en Cataluña y comparación con Europa. Med Clin (Barc) 2008 131 (Suppl. 1 19 24.
35. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009 45 : 931 991.
36. Streetly A, Markowe H. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 1995 24 : 897 907.
37. Borras J, Ameijide A, Vilardell L, Valls J, Marcos-Gragera R, Izquierdo A. Trends in cancer incidence in Catalonia, 1985-2002. Med Clin (Barc) 2008 131 (Suppl.1 11 18.